Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
6
×
life sciences
national blog main
national top stories
new york blog main
6
×
boston blog main
boston top stories
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
merck
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston
cancer
eli lilly
pfizer
4d molecular therapeutics
acne
agenus
aimmune therapeutics
What
approved
6
×
fda
drug
medicine
new
oks
specifically
time
treat
treatment
adults
afternoon
agency
aimmune
allergan
allergy
alnylam
alnylam’s
approval
awarded
bio
brexanolone
cancer
class
companies
deeper
depression
devastating
developed
digital
disease
disorder
dna
epidemic
fast
fatty
fingerprint
frenzied
friday
genetic
Language
unset
Current search:
fda
×
approved
×
" new york blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug